New research suggests mitochondria may cure diabetes

Mitochondria play a crucial role in cellular energy production, and their dysfunction has long been linked to metabolic diseases such as type 2 diabetes. Individuals with this condition either struggle to produce enough insulin or cannot effectively use the insulin their pancreas produces to regulate blood sugar levels.

While previous studies have highlighted abnormal mitochondrial structures in insulin-producing pancreatic β-cells, they have yet to fully explain why these cells malfunction.

A study published in Science by researchers at the University of Michigan offers new insights into this process. Using mice, the team demonstrated that mitochondrial defects trigger a stress response that alters the maturation and function of β-cells. This finding sheds light on a previously unexplored pathway that may be central to diabetes development.

Mitochondria are responsible for generating the energy cells need to function. However, defects in these structures can lead to broad metabolic impairments, as seen in individuals with type 2 diabetes.

Research has already established that pancreatic β-cells from diabetic patients exhibit abnormal mitochondria and reduced energy production. Skeletal muscle cells, visceral fat, and liver tissues also show signs of mitochondrial dysfunction, which impacts their ability to process insulin and regulate metabolism.

The study, published in the journal Science and led by Emily M. Walker, Ph.D., a research assistant professor of internal medicine, sought to identify the molecular pathways that maintain mitochondrial health. To do this, the researchers disrupted three key mitochondrial processes in mice: mitochondrial DNA integrity, mitochondrial recycling via mitophagy, and mitochondrial quality control mechanisms.

“In all three cases, the exact same stress response was turned on, which caused β-cells to become immature, stop making enough insulin, and essentially stop being β-cells,” Walker explained. The study's results revealed that malfunctioning mitochondria send distress signals to the nucleus, ultimately altering the fate of the cell. These findings were further validated in human pancreatic islet cells.

Since diabetes impacts multiple organs, the research team expanded their investigation beyond pancreatic β-cells. They examined liver cells and fat-storing cells in mice, expecting to find similar stress responses.

“Diabetes is a multi-system disease—you gain weight, your liver produces too much sugar, and your muscles are affected. That’s why we wanted to look at other tissues as well,” said Scott A. Soleimanpour, M.D., director of the Michigan Diabetes Research Center and senior author of the study.

The team found that liver and fat cells exhibited the same mitochondrial stress response observed in pancreatic β-cells. These cells failed to mature and function properly, reinforcing the idea that mitochondrial dysfunction plays a widespread role in diabetes-related complications.

Although the researchers did not examine every tissue type affected by diabetes, their findings suggest that this mitochondrial pathway could contribute to dysfunction across multiple organ systems.

One of the most striking aspects of the study was the discovery that mitochondrial damage did not result in cell death. Instead, the affected cells remained alive but in a dysfunctional, immature state. This raised the possibility that reversing mitochondrial damage could restore normal cell function.

To test this, the researchers treated the diabetic mice with ISRIB, a drug that blocks the stress response triggered by mitochondrial dysfunction. After four weeks of treatment, the β-cells regained their ability to regulate glucose levels, suggesting that the damage could be reversed.

“Losing your β-cells is the most direct path to getting type 2 diabetes. Through our study, we now have an explanation for what might be happening and how we can intervene and fix the root cause,” Soleimanpour said.

The findings offer a promising new approach for treating diabetes at its root cause rather than just managing symptoms. The research team is now working to further dissect the molecular pathways involved in mitochondrial stress responses. They hope to replicate their results using human cell samples from diabetic patients.

Mitochondrial dysfunction has long been recognized as a hallmark of metabolic diseases, but this study provides new evidence that it actively drives disease progression by altering cellular identity. By targeting the mitochondrial stress response, scientists may be able to restore proper cellular function and develop more effective treatments for diabetes.

The implications extend beyond diabetes, as mitochondrial dysfunction is also linked to other metabolic disorders. Understanding how mitochondria communicate with the nucleus to influence cell fate could open new avenues for treating a wide range of diseases. With further research, these findings could revolutionize the way diabetes and other metabolic conditions are treated in the future.

Note: Materials provided above by The Brighter Side of News. Content may be edited for style and length.

Like these kind of feel good stories? Get The Brighter Side of News' newsletter.